Isotope-Labeled Compounds

Isotope-labeled compounds are chemical substances in which some atoms in their molecules are replaced by isotope atoms. The range of stable isotope products can cover from gases to complex molecules. Isotope-labeled compounds could provide a site-specific investigation of structures, making molecules easily detectable by mass spectrometry and NMR, and maintaining the physico-chemical properties of the target molecule at the same time. MCE isotope-labeled compounds are all stable isotope-labeled compounds and are non-radioactive labeled substances. MCE isotope-labeled compounds are unique tools for identifying and understanding biological and chemical processes. Stable isotope-labeled products are now getting more and more popular among scientists. The scope of application is gradually penetrating into various scientific fields, such as life sciences, food and medicine, agriculture, environment, geology, etc. Stable isotope-labeled compounds have a wide range of applications in the Life Science areas, such as Metabolomics, Proteomics, Clinical studies, Deuterium drugs, etc.

Isotope-Labeled Compounds Inhibitors (2)

Isotope-Labeled Compounds Related Products (9621):

Cat. No.	Product Name	Effect	Purity	Chemical Structure

HY-76025S

1,4-Dibromobenzene-d₄		99.90%
1,4-Dibromobenzene-d₄ is a deuterium labeled 1,4-Dibromobenzene. 1,4-Dibromobenzene is used as a fumigant and as a chemical intermediate for pharmaceuticals. Inhalation exposure gives rise to dizziness and chokingwhereas contact with skin or eye produces inflammation and burning in humans.

HY-W008151S

Diphenyl Phosphate-d₁₀
Diphenyl Phosphate-d₁₀ (DPhP-d₁₀) is the deuterium labled Diphenyl Phosphate (HY-W008151). Diphenyl Phosphate inhibits growth and energy metabolism of zebrafish in a sex-specific manner.

HY-W018772S10

D-Ribose-d₂		≥98.0%
D-Ribose-d₂ is the deuterium labeled D-Ribose. D-Ribose is an energy enhancer, and acts as a sugar moiety of ATP, and widely used as a metabolic therapy supplement for chronic fatigue syndrome or cardiac energy metabolism. D-Ribose is active in protein gl

HY-N0830S18

Palmitic acid-d		99.90%
Palmitic acid-d is the deuterium labeled Palmitic acid. Palmitic acid is a long-chain saturated fatty acid commonly found in both animals and plants. PA can induce the expression of glucose-regulated protein 78 (GRP78) and CCAAT/enhancer binding protein homologous protein (CHOP) in in mouse granulosa cells.

HY-N0326S10

L-Methionine-d₄
L-Methionine-d₄ is the deuterium labeled L-Methionine. L-Methionine is the L-isomer of Methionine, an essential amino acid for human development. Methionine acts as a hepatoprotectant.

HY-Y1354S

Dimethylamine-d₆ hydrochloride		≥98.0%
Dimethylamine-d₆ hydrochloride is a deuterium labeled Dimethylamine hydrochloride. Dimethylamine hydrochloride is the immediate precursor of dimethylnitrosamine, a known potent carcinogen in a wide variety of animal species.

HY-143996S

Mevalonic acid-¹³C,d₃ sodium		≥99.0%
Mevalonic acid-¹³C,d₃ (sodium) is the ¹³C- and deuterium labeled Mevalonic acid.

HY-W585839S

Bis(2-chloroethyl) phosphate-d₈		99.90%
Bis(2-chloroethyl) phosphate-d₈ is a deuterium labeled compound.

HY-W010708S1

Cholesteryl palmitate-d₇		99.00%
Cholesteryl palmitate-d₇ is deuterium labeled Cholesteryl palmitate. Cholesteryl palmitate is a useful prognostic biomarker for chronic interstitial pneumonia (CIP).

HY-W016498S1

Paraxanthine-¹³C₄,¹⁵N₃		99.80%
Paraxanthine-¹³C₄,¹⁵N₃ is the ¹³C-labeled and ¹⁵N-labeled Paraxanthine. Paraxanthine, a caffeine metabolite, provides protection against Dopaminergic cell death via stimulation of Ryanodine Receptor Channels.

HY-169326S

JAK2-IN-11		98.03%
JAK2-IN-11 (Example 6) is a JAK2 kinase inhibitor with IC₅₀ ≤10 nM against JH2 BIND WT/V617F. JAK2-IN-11 has antitumor activity.

HY-113225S3

Guanosine triphosphate-¹⁵N₅ dilithium
Guanosine triphosphate-¹⁵N₅ (GTP-¹⁵N₅) dilithium is ¹⁵N labeled Guanosine triphosphate (HY-113225). Guanosine triphosphate is a native nucleotide. The derivatives of GTP may be used as specific inhibitors against COVID-19.

HY-14763S1

Cariprazine-d₈		99.51%
Cariprazine-d₈ is a deuterium labeled Cariprazine. Cariprazine is a novel antipsychotic agent candidate that exhibits high affinity for the D3 (Ki=0.085 nM) and D2 (Ki=0.49 nM) receptors, and moderate affinity for the 5-HT1A receptor (Ki=2.6 nM).

HY-W026772S

Fluorene-d₁₀		≥99.0%
Fluorene-d₁₀ is the deuterium labeled Fluorene. Fluorene, a polycyclic aromatic hydrocarbon (PAH), is a precursor to other fluorene compounds. Fluorene and its derivative?can be used as a precursor to fluorene-based dyes.

HY-W015998S

(R)-(+)-Warfarin-d₅		99.23%
(R)-(+)-Warfarin-d₅ is deuterium labeled (R)-(+)-Warfarin.

HY-B0254S

Glipizide-d₁₁
Glipizide-d₁₁ is the deuterium labeled Glipizide. Glipizide (CP 2872; K 4024)?a potent, orally active and sulfonylurea class anti-diabetic agent and can be used for type 2?diabetes mellitus research but not type 1. Glipizide acts by partially blocking ATP-sensitive potassium?(KATP) channels among β cells of pancreatic islets of Langerhans.

HY-W013504S

1-Bromo-4-(trifluoromethyl)benzene-d₄
1-Bromo-4-(trifluoromethyl)benzene-d₄ is the deuterium labeled 1-Bromo-4-(trifluoromethyl)benzene.

HY-130321S1

Lauroyl-L-carnitine-d₉ chloride		≥98.0%
Lauroyl-L-carnitine-d₉ chloride is the deuterium labeled Lauroyl-L-carnitine (HY-130321). Lauroyl-L-carnitine chloride can be used as an absorption enhancer.

HY-125818S3

Cytidine-5'-triphosphate-¹³C₉ dilithium		99.0%
Cytidine-5'-triphosphate-¹³C₉ (Cytidine triphosphate-¹³C₉ dilithium; 5'-CTP-¹³C₉) dilithium is ¹³C-labeled Cytidine-5'-triphosphate (HY-125818). Cytidine 5′-triphosphate (Cytidine triphosphate; 5'-CTP) is a nucleoside triphosphate and serves as a building block for nucleotides and nucleic acids, lipid biosynthesis. Cytidine triphosphate synthase can catalyze the formation of cytidine 5′-triphosphate from uridine 5′-triphosphate (UTP). Cytidine 5′-triphosphate is an essential biomolecule?in the de novo?pyrimidine biosynthetic pathway in?T. gondii.

HY-B1221S1

Flufenamic acid-¹³C₆
Flufenamic acid-¹³C₆ is the ¹³C₆ labeled Flufenamic acid. Flufenamic acid is a non-steroidal anti-inflammatory agent, inhibits cyclooxygenase (COX), activates AMPK, and also modulates ion channels, blocking chloride channels and L-type Ca²⁺ channels, modulating non-selective cation channels (NSC), activating K+ channels. Flufenamic acid binds to the central pocket of TEAD2 YBD and inhibits both TEAD function and TEAD-YAP-dependent processes, such as cell migration and proliferation.

Name
Email *

	Sorry, but the email address you supplied was invalid.